Mira Harrison-Woolrych is an Honorary Research Associate Professor at the Dunedin School of Medicine, University of Otago, New Zealand (NZ). She has worked on women’s medicines for over 20 years, having first trained in clinical obstetrics and gynaecology.  Dr Harrison-Woolrych has significant experience in research, medicines regulation and pharmacovigilance in the UK and NZ. As Director of the Intensive Medicines Monitoring Programme for ten years, she led pharmacoepidemiology research studies on many different medicines and intrauterine devices, resulting in an extensive list of publications in high-ranking journals.  Dr Harrison-Woolrych is a Fellow of the Royal College of Obstetricians and Gynaecologists and has served on several government advisory committees as an expert on women’s medicines. She was also elected to the Executive Committee of the International Society of Pharmacovigilance (ISoP) and leads the ISoP Women’s Medicines Research Group. The international networks developed in these roles have enabled her to draw on a wealth of expertise from the other authors who have contributed chapters to this extraordinary book.

• Part 1 Prescribing medicines for women: general principles and consideration of special sub-populations. - 1 Medicines for women: medicines for half the world. - 2 Effects of sex differences in the pharmacokinetics of drugs and their impact on the safety of medicines in women. - 3 Prescribing Medicines to Adolescent Women. - 4 Medication Use in Pregnancy; Treating the Mother - Protecting the Unborn. - Part 2 Specific medicinal products for women: benefits and risks. - 5 Oral Contraceptives: Benefits and risks. - 6 Oral Contraceptives and the Risk of Venous Thromboembolism. - 7 Emergency Contraception. - 8 Contraceptive devices for women: implants, intrauterine devices and other products. - 9 HPV vaccines. - 10 Medical treatment of chronic pelvic pain. - 11 Menopausal hormone therapy: a safety perspective. - 12 Bisphosphonates for Osteoporosis. - 13 Herbal and Complementary Medicines used for Women’s Health. - Part 3 International perspectives on medicines for women and risk communication. - 14 A Primary Care Perspective on Prescribing for Women. - 15 A Medicines Regulatory Perspective on Women’s Medicines. - 16 Political and religious perspectives on managing the risks and benefits of women’s medicines. - 17 Perspectives on women’s health and medicines in developing countries. - 18 Perspectives on risk communication and gender issues. - 19 Risk communication and specific medicines for women.

Mira Harrison-Woolrych is an Honorary Research Associate Professor at the Dunedin School of Medicine, University of Otago, New Zealand (NZ). She has worked on women’s medicines for over 20 years, having first trained in clinical obstetrics and gynaecology.  Dr Harrison-Woolrych has significant experience in research, medicines regulation and pharmacovigilance in the UK and NZ. As Director of the Intensive Medicines Monitoring Programme for ten years, she led pharmacoepidemiology research studies on many different medicines and intrauterine devices, resulting in an extensive list of publications in high-ranking journals.  Dr Harrison-Woolrych is a Fellow of the Royal College of Obstetricians and Gynaecologists and has served on several government advisory committees as an expert on women’s medicines. She was also elected to the Executive Committee of the International Society of Pharmacovigilance (ISoP) and leads the ISoP Women’s Medicines Research Group. The international networks developed in these roles have enabled her to draw on a wealth of expertise from the other authors who have contributed chapters to this extraordinary book.

• Part 1 Prescribing medicines for women: general principles and consideration of special sub-populations. - 1 Medicines for women: medicines for half the world. - 2 Effects of sex differences in the pharmacokinetics of drugs and their impact on the safety of medicines in women. - 3 Prescribing Medicines to Adolescent Women. - 4 Medication Use in Pregnancy; Treating the Mother - Protecting the Unborn. - Part 2 Specific medicinal products for women: benefits and risks. - 5 Oral Contraceptives: Benefits and risks. - 6 Oral Contraceptives and the Risk of Venous Thromboembolism. - 7 Emergency Contraception. - 8 Contraceptive devices for women: implants, intrauterine devices and other products. - 9 HPV vaccines. - 10 Medical treatment of chronic pelvic pain. - 11 Menopausal hormone therapy: a safety perspective. - 12 Bisphosphonates for Osteoporosis. - 13 Herbal and Complementary Medicines used for Women’s Health. - Part 3 International perspectives on medicines for women and risk communication. - 14 A Primary Care Perspective on Prescribing for Women. - 15 A Medicines Regulatory Perspective on Women’s Medicines. - 16 Political and religious perspectives on managing the risks and benefits of women’s medicines. - 17 Perspectives on women’s health and medicines in developing countries. - 18 Perspectives on risk communication and gender issues. - 19 Risk communication and specific medicines for women.

Mira Harrison-Woolrych is an Honorary Research Associate Professor at the Dunedin School of Medicine, University of Otago, New Zealand (NZ). She has worked on women’s medicines for over 20 years, having first trained in clinical obstetrics and gynaecology.  Dr Harrison-Woolrych has significant experience in research, medicines regulation and pharmacovigilance in the UK and NZ. As Director of the Intensive Medicines Monitoring Programme for ten years, she led pharmacoepidemiology research studies on many different medicines and intrauterine devices, resulting in an extensive list of publications in high-ranking journals.  Dr Harrison-Woolrych is a Fellow of the Royal College of Obstetricians and Gynaecologists and has served on several government advisory committees as an expert on women’s medicines. She was also elected to the Executive Committee of the International Society of Pharmacovigilance (ISoP) and leads the ISoP Women’s Medicines Research Group. The international networks developed in these roles have enabled her to draw on a wealth of expertise from the other authors who have contributed chapters to this extraordinary book.

• Part 1 Prescribing medicines for women: general principles and consideration of special sub-populations. - 1 Medicines for women: medicines for half the world. - 2 Effects of sex differences in the pharmacokinetics of drugs and their impact on the safety of medicines in women. - 3 Prescribing Medicines to Adolescent Women. - 4 Medication Use in Pregnancy; Treating the Mother - Protecting the Unborn. - Part 2 Specific medicinal products for women: benefits and risks. - 5 Oral Contraceptives: Benefits and risks. - 6 Oral Contraceptives and the Risk of Venous Thromboembolism. - 7 Emergency Contraception. - 8 Contraceptive devices for women: implants, intrauterine devices and other products. - 9 HPV vaccines. - 10 Medical treatment of chronic pelvic pain. - 11 Menopausal hormone therapy: a safety perspective. - 12 Bisphosphonates for Osteoporosis. - 13 Herbal and Complementary Medicines used for Women’s Health. - Part 3 International perspectives on medicines for women and risk communication. - 14 A Primary Care Perspective on Prescribing for Women. - 15 A Medicines Regulatory Perspective on Women’s Medicines. - 16 Political and religious perspectives on managing the risks and benefits of women’s medicines. - 17 Perspectives on women’s health and medicines in developing countries. - 18 Perspectives on risk communication and gender issues. - 19 Risk communication and specific medicines for women.